IP Library Granted Patent US 9,688,994
Granted Patent B2
US 9,688,994 · App. 13/954,351 · Granted Jun 27, 2017

Methods of introducing nucleic acids into cellular DNA

Inventors: Marc J. Lajoie (Cambridge, MA); Christopher J. Gregg (Roslindale, MA); Joshua A. Mosberg (Cambridge, MA); George M. Church (Brookline, MA)
Assignee: President and Fellows of Harvard College
C12N15/70C12N15/102C12N15/1024
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,688,994
App. No.
13/954,351
Granted
Jun 27, 2017
Kind
B2
Abstract

A method of introducing a nucleic acid sequence into a cell is provided where the cell has impaired or inhibited or disrupted DnaG primase activity or impaired or inhibited or disrupted DnaB helicase activity, or larger or increased gaps or distance between Okazaki fragments or lowered or reduced frequency of Okazaki fragment initiation, or the cell has increased single stranded DNA (ssDNA) on the lagging strand of the replication fork including transforming the cell through recombination with a nucleic acid oligomer.

Claims (18)

1. A method of introducing a nucleic acid sequence into the genome of a cell where the cell has impaired or inhibited or disrupted DnaG primase activity, or impaired or inhibited or disrupted DnaB helicase activity, comprising transforming the cell with a nucleic acid oligomer, wherein the nucleic acid oligomer is introduced into the genome of the cell through recombination, and wherein the nucleic acid oligomer is single-stranded DNA.

2. The method of claim 1 wherein the cell is transformed with multiple nucleic acid oligomers.

3. The method of claim 1 , wherein multiple mutations are generated in a chromosome of the cell through recombination.

4. The method of claim 1 , wherein multiple mutations are generated in the genome of the cell through recombination.

5. The method of claim 1 , wherein the cell is contacted with a pool of nucleic acid oligomers.

6. The method of claim 1 wherein the cell is deficient in at least one nuclease.

7. The method of claim 1 wherein the cell is grown into a population of cells having impaired or inhibited or disrupted DnaG primase activity or impaired or inhibited or disrupted DnaB helicase activity, and the population of cells is transformed with at least one nucleic acid oligomer.

8. The method of claim 1 wherein the cell is grown into a population of cells having impaired or inhibited or disrupted DnaG primase activity or impaired or inhibited or disrupted DnaB helicase activity, and the population of cells is transformed with at least one nucleic acid oligomer and the steps of growing and transforming are repeated until a plurality of nucleic acid sequences have been introduced into the cells.

9. A method of serially introducing a nucleic acid sequence into the genome of a cell where the cell has impaired or inhibited or disrupted DnaG primase activity or impaired or inhibited or disrupted DnaB helicase activity, comprising transforming the cell with a nucleic acid oligomer two or more times, wherein the nucleic acid oligomer is introduced into the genome of the cell through recombination, and wherein the nucleic acid oligomer is single-stranded DNA.

10. The method of claim 9 wherein the cell is transformed with multiple nucleic acid oligomers.

11. The method of claim 9 , wherein multiple mutations are generated in a chromosome of the cell through recombination.

12. The method of claim 9 , wherein multiple mutations are generated in the genome of the cell through recombination.

13. The method of claim 9 , wherein the cell is contacted with a pool of nucleic acid oligomers.

14. The method of claim 9 wherein the cell is deficient in at least one nuclease.

15. The method of claim 9 wherein the cell is grown into a population of cells having impaired or inhibited or disrupted DnaG primase activity or impaired or inhibited or disrupted DnaB helicase activity, and the population of cells is transformed with at least one nucleic acid oligomer.

16. The method of claim 9 wherein the cell is grown into a population of cells having impaired or inhibited or disrupted DnaG primase activity or impaired or inhibited or disrupted DnaB helicase activity, and the population of cells is transformed with at least one nucleic acid oligomer and the steps of growing and transforming are repeated until a plurality of nucleic acid sequences have been introduced into the cells.

17. A method of introducing a nucleic acid sequence into the genome of a cell where the cell has impaired or inhibited or disrupted DnaG primase activity or impaired or inhibited or disrupted DnaB helicase activity, and is deficient in at least one nuclease comprising transforming the cell with a nucleic acid oligomer, wherein the nucleic acid oligomer is introduced into the genome of the cell through recombination, and wherein the nucleic acid oligomer is single-stranded DNA.

18. The method of claim 17 wherein a plurality of eXogenous nucleic acid sequences are introduced through recombination into the genome of the cells having impaired or inhibited or disrupted DnaG primase activity or impaired or inhibited or disrupted DnaB helicase activity, and being deficient in at least one nuclease.

Assignments (3)
CONFIRMATORY LICENSE Recorded Feb 5, 2014
From: HARVARD UNIVERSITY
To: ENERGY, UNITED STATES DEPARTMENT OF
Reel/Frame 032180/0840 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 16, 2013
From: CHURCH, GEORGE M.; GREGG, CHRISTOPHER; LAJOIE, MARC J.; MOSBERG, JOSHUA A.
To: PRESIDENT AND FELLOWS OF HARVARD COLLEGE
Reel/Frame 031413/0184 →
CONFIRMATORY LICENSE Recorded Sep 27, 2013
From: HARVARD UNIVERSITY
To: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
Reel/Frame 031305/0286 →
Continuity (2)
Provisional Application 61677375 · Jul 30, 2012
Related Publication 20140045267A1 · Feb 13, 2014